PMN
PMN
NASDAQ · Biotechnology

Promis Neurosciences Inc

Biotech Stocks Healthcare Stocks
$13.16
+2.41 (+22.42%)
As of Jun 30, 10:46 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +74.8% upside
Low Target $15.62
Average Target $23.00
High Target $28.09
Current Price $13.16
Current
$13.16
Target
$23.00
$15.62 $23.00 avg $28.09
Scenario Analysis
Bear Case
$15.62
18.7%
Low target
Base Case
$23.00
+74.8%
Avg target
Bull Case
$28.09
+113.4%
High target
Risk/Reward
6.1x
Highly favorable
Price in Context
52-Week High
$39.75
-66.9% from high
52-Week Low
$6.27
+109.9% from low
Target vs 52W High
$23.00
-42.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -47.4%